Helen Torley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Helen Torley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Helen Torley. Helen Torley is Chief Opertaing Officer in ONYX PHARMACEUTICALS INC ($ONXX) and EVP & Chief Commercial Officer in ONYX PHARMACEUTICALS INC ($ONXX) and Director in QUEST DIAGNOSTICS INC ($DGX) and President and CEO in HALOZYME THERAPEUTICS INC ($GYHT) and Director in Relypsa Inc ($RLYP).
Latest Insider Trading Transactions of Helen Torley
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GYHT, ONXX, DGX, RLYP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 400,000 | |
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 39.66 | 50,000 | 1,982,950 | 537,160 | 587.2 K to 537.2 K (-8.52 %) |
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 14.66 | 50,000 | 733,000 | 587,160 | 537.2 K to 587.2 K (+9.31 %) |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 500,000 | |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 42.55 | 50,000 | 2,127,250 | 537,160 | 587.2 K to 537.2 K (-8.52 %) |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 14.66 | 50,000 | 733,000 | 587,160 | 537.2 K to 587.2 K (+9.31 %) |
| Mar 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 550,000 | |
| Mar 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 46.48 | 33,890 | 1,575,112 | 537,160 | 571.1 K to 537.2 K (-5.93 %) |
| Mar 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 45.58 | 16,110 | 734,342 | 571,050 | 587.2 K to 571.1 K (-2.74 %) |
| Mar 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 14.66 | 50,000 | 733,000 | 587,160 | 537.2 K to 587.2 K (+9.31 %) |
| Feb 22 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 39,354 | 0 | 0 | |
| Feb 22 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 48.69 | 19,511 | 949,991 | 537,160 | 556.7 K to 537.2 K (-3.50 %) |
| Feb 22 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 39,354 | 0 | 556,671 | 517.3 K to 556.7 K (+7.61 %) |
| Feb 17 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 52,368 | 0 | 52,368 | |
| Feb 17 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 49.84 | 90,134 | 4,492,279 | 90,134 | |
| Feb 16 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 28,729 | 0 | 28,729 | |
| Feb 16 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 49.84 | 14,243 | 709,871 | 517,317 | 531.6 K to 517.3 K (-2.68 %) |
| Feb 16 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 28,729 | 0 | 531,560 | 502.8 K to 531.6 K (+5.71 %) |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 32,795 | 0 | 65,589 | |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 31,282 | 0 | 93,844 | |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 49.84 | 16,259 | 810,349 | 502,831 | 519.1 K to 502.8 K (-3.13 %) |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 32,795 | 0 | 519,090 | 486.3 K to 519.1 K (+6.74 %) |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 50.60 | 15,509 | 784,755 | 486,295 | 501.8 K to 486.3 K (-3.09 %) |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 31,282 | 0 | 501,804 | 470.5 K to 501.8 K (+6.65 %) |
| Feb 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 600,000 | |
| Feb 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 48.51 | 5,437 | 263,736 | 470,522 | 476 K to 470.5 K (-1.14 %) |
| Feb 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 47.76 | 44,563 | 2,128,182 | 475,959 | 520.5 K to 476 K (-8.56 %) |
| Feb 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 14.66 | 50,000 | 733,000 | 520,522 | 470.5 K to 520.5 K (+10.63 %) |
| Nov 30 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Gift | G | 0.00 | 10,000 | 0 | 470,522 | 480.5 K to 470.5 K (-2.08 %) |
| May 21 2020 | DGX | QUEST DIAGNOSTICS ... | Torley Helen | Director | Grant | A | 0.00 | 1,531 | 0 | 4,897 | 3.4 K to 4.9 K (+45.48 %) |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 39,354 | 0 | 39,354 | |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 21.83 | 19,511 | 425,925 | 490,522 | 510 K to 490.5 K (-3.83 %) |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 39,354 | 0 | 510,033 | 470.7 K to 510 K (+8.36 %) |
| Feb 18 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 28,730 | 0 | 57,458 | |
| Feb 18 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 21.10 | 14,244 | 300,548 | 470,679 | 484.9 K to 470.7 K (-2.94 %) |
| Feb 18 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 28,730 | 0 | 484,923 | 456.2 K to 484.9 K (+6.30 %) |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 32,795 | 0 | 98,384 | |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 20.00 | 16,259 | 325,180 | 456,193 | 472.5 K to 456.2 K (-3.44 %) |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 32,795 | 0 | 472,452 | 439.7 K to 472.5 K (+7.46 %) |
| Feb 12 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 125,126 | 0 | 125,126 | |
| Feb 12 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 19.98 | 266,051 | 5,315,699 | 266,051 | |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 55,487 | 0 | 0 | |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 19.21 | 19,910 | 382,471 | 439,657 | 459.6 K to 439.7 K (-4.33 %) |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 55,487 | 0 | 459,567 | 404.1 K to 459.6 K (+13.73 %) |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 55,487 | 0 | 0 | |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 19.21 | 19,910 | 382,471 | 439,657 | 459.6 K to 439.7 K (-4.33 %) |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 55,487 | 0 | 459,567 | 404.1 K to 459.6 K (+13.73 %) |
| Feb 22 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 39,354 | 0 | 78,708 | |
| Feb 22 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 16.81 | 19,511 | 327,980 | 416,580 | 436.1 K to 416.6 K (-4.47 %) |
| Feb 22 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 39,354 | 0 | 436,091 | 396.7 K to 436.1 K (+9.92 %) |
| Feb 15 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 28,730 | 0 | 86,188 | |
| Feb 15 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 16.54 | 14,244 | 235,596 | 396,737 | 411 K to 396.7 K (-3.47 %) |
| Feb 15 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 28,730 | 0 | 410,981 | 382.3 K to 411 K (+7.52 %) |
| Feb 14 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 131,179 | 0 | 131,179 | |
| Feb 14 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 16.65 | 250,218 | 4,166,130 | 250,218 | |
| Feb 06 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 31,250 | 0 | 0 | |
| Feb 06 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 16.73 | 14,547 | 243,371 | 382,251 | 396.8 K to 382.3 K (-3.67 %) |
| Feb 06 2019 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 31,250 | 0 | 396,798 | 365.5 K to 396.8 K (+8.55 %) |
| Oct 03 2018 | DGX | QUEST DIAGNOSTICS ... | Torley Helen | Director | Option Exercise | A | 108.35 | 1,298 | 140,632 | 1,298 | |
| Jul 05 2018 | DGX | QUEST DIAGNOSTICS ... | Torley Helen | Director | Option Exercise | A | 109.51 | 1,297 | 142,034 | 1,297 | |
| Jun 05 2018 | DGX | QUEST DIAGNOSTICS ... | Torley Helen | Director | Option Exercise | A | 107.18 | 665 | 71,275 | 665 | |
| May 17 2018 | DGX | QUEST DIAGNOSTICS ... | Torley Helen | Director | Grant | A | 0.00 | 1,644 | 0 | 1,644 | 0 to 1.6 K |
| Feb 23 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 39,354 | 0 | 118,062 | |
| Feb 23 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 19.28 | 19,511 | 376,172 | 329,486 | 349 K to 329.5 K (-5.59 %) |
| Feb 23 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 39,354 | 0 | 348,997 | 309.6 K to 349 K (+12.71 %) |
| Feb 16 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 114,918 | 0 | 114,918 | |
| Feb 16 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 18.41 | 201,552 | 3,710,572 | 201,552 | |
| Feb 06 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 31,250 | 0 | 31,250 | |
| Feb 06 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 18.25 | 15,493 | 282,747 | 309,643 | 325.1 K to 309.6 K (-4.77 %) |
| Feb 06 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 31,250 | 0 | 325,136 | 293.9 K to 325.1 K (+10.63 %) |
| Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 55,487 | 0 | 110,974 | |
| Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 18.37 | 24,111 | 442,919 | 293,886 | 318 K to 293.9 K (-7.58 %) |
| Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 55,487 | 0 | 317,997 | 262.5 K to 318 K (+21.14 %) |
| Jan 09 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 0 | |
| Jan 09 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 19.46 | 11,649 | 226,690 | 262,510 | 274.2 K to 262.5 K (-4.25 %) |
| Jan 09 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 274,159 | 244.2 K to 274.2 K (+12.29 %) |
| Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 157,416 | 0 | 157,416 | |
| Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 12.07 | 251,923 | 3,040,711 | 251,923 | |
| Feb 07 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 31,250 | 0 | 62,500 | |
| Feb 07 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 31,250 | 0 | 244,159 | 212.9 K to 244.2 K (+14.68 %) |
| Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 55,487 | 0 | 166,461 | |
| Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 55,487 | 0 | 212,909 | 157.4 K to 212.9 K (+35.25 %) |
| Jan 09 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 30,000 | |
| Jan 09 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 157,422 | 127.4 K to 157.4 K (+23.54 %) |
| Sep 02 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Option Exercise | D | 17.00 | 4,500 | 76,500 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Option Exercise | D | 35.79 | 4,500 | 161,055 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Option Exercise | D | 36.83 | 12,000 | 441,960 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Sell | D | 32.00 | 2,250 | 72,000 | 0 | 2.3 K to 0 (-100.00 %) |
| Sep 02 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Sell | U | 32.00 | 1,237 | 39,584 | 2,250 | 3.5 K to 2.3 K (-35.47 %) |
| Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 13,500 | 0 | 0 | |
| Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 13,500 | 0 | 13,500 | |
| Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 8.63 | 7,044 | 60,790 | 127,422 | 134.5 K to 127.4 K (-5.24 %) |
| Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 13,500 | 0 | 134,466 | 121 K to 134.5 K (+11.16 %) |
| Jun 23 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Option Exercise | A | 17.00 | 4,500 | 76,500 | 4,500 | |
| Jun 23 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Grant | A | 0.00 | 2,250 | 0 | 3,487 | 1.2 K to 3.5 K (+181.89 %) |
| Jun 08 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Sell | S | 19.32 | 1,013 | 19,570 | 1,237 | 2.3 K to 1.2 K (-45.02 %) |
| Feb 09 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 31,250 | 0 | 93,750 | |
| Feb 09 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 7.90 | 11,743 | 92,770 | 120,966 | 132.7 K to 121 K (-8.85 %) |
| Feb 09 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 31,250 | 0 | 132,709 | 101.5 K to 132.7 K (+30.80 %) |
| Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 221,948 | 0 | 221,948 | |
| Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 8.11 | 376,569 | 3,053,975 | 376,569 | |
| Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 60,000 | |
| Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 15.77 | 11,686 | 184,288 | 101,459 | 113.1 K to 101.5 K (-10.33 %) |
| Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 113,145 | 83.1 K to 113.1 K (+36.08 %) |
| Jan 04 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 17.33 | 16,436 | 284,836 | 83,145 | 99.6 K to 83.1 K (-16.51 %) |
| Jan 04 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Grant | A | 0.00 | 31,500 | 0 | 99,581 | 68.1 K to 99.6 K (+46.27 %) |
| Jun 08 2015 | RLYP | Relypsa Inc | Torley Helen | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
| Jun 08 2015 | RLYP | Relypsa Inc | Torley Helen | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
| Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP & Chief Commerc ... | Sell | S | 71.89 | 2,000 | 143,780 | 58,701 | 60.7 K to 58.7 K (-3.29 %) |
| Jul 27 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Sell | S | 73.97 | 4,549 | 336,498 | 60,701 | 65.3 K to 60.7 K (-6.97 %) |
| Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Option Exercise | A | 37.68 | 18,300 | 689,544 | 18,300 | |
| Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 17,150 | 0 | 65,250 | 48.1 K to 65.3 K (+35.65 %) |
| Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 3,600 | 0 | 48,100 | 44.5 K to 48.1 K (+8.09 %) |
| Oct 27 2011 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 10,000 | 0 | 44,500 | 34.5 K to 44.5 K (+28.99 %) |
| Aug 31 2011 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Option Exercise | A | 33.70 | 84,000 | 2,830,800 | 84,000 | |
| Aug 31 2011 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 22,500 | 0 | 34,500 | 12 K to 34.5 K (+187.50 %) |
| Aug 31 2011 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Page: 1